Corrigendum to "Automated cassette-based production of high specific activity [^203/212Pb]peptide-based theranostic radiopharmaceuticals for image-guided radionuclide therapy for cancer" [Appl. Radiat. Isot. 127 (2017) 52-60]

Affiliations

• ¹ Interdisciplinary Graduate Program in Human Toxicology, University of Iowa, Iowa City, IA, USA.
• ² Department of Biochemistry, University of Missouri, Columbia, MO, USA.
• ³ Stead Family Department of Pediatrics, University of Iowa, Iowa City, IA, USA.
• ⁴ Eckert & Ziegler Radiopharma GmbH, Berlin, Germany.
• ⁵ National Institute of Standards and Technology, Gaithersburg, MD, USA.
• ⁶ Eichrom Technologies, LLC, Lisle, IL, USA.
• ⁷ Lantheus Medical Imaging, North Billerica, MA, USA.
• ⁸ Department of Radiology, The University of Iowa, Iowa City, IA, USA.
• ⁹ Oak Ridge National Laboratory, The US Department of Energy, Oak Ridge TN, USA.
• ¹⁰ Viewpoint Molecular Targeting, LLC, Coralville, IA, USA; Department of Internal Medicine, Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA.
• ¹¹ Interdisciplinary Graduate Program in Human Toxicology, University of Iowa, Iowa City, IA, USA; Stead Family Department of Pediatrics, University of Iowa, Iowa City, IA, USA; Department of Radiology, The University of Iowa, Iowa City, IA, USA; Viewpoint Molecular Targeting, LLC, Coralville, IA, USA; Department of Radiation Oncology (Free Radical and Radiation Biology Program), Carver College of Medicine, University of Iowa, Iowa City, IA, USA; Department of Chemistry, University of Iowa, Iowa City, IA, USA. Electronic address: michael-schultz@uiowa.edu.